Clinical Trial Update: Impact of Liposomal Bupivacaine Administered Following Placement of a Transobturator Suburethral Sling [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating liposomal bupivacaine for postoperative pain after transobturator suburethral sling placement was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: TriHealth Inc. | Conditions: Pain | Phase 4 | Status: TERMINATED